Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for March 5th, 2012

« Older Entries

Improving Adherence to Web-Based Cessation Programs: A Social Network Approach

By on Monday, March 5th, 2012 | No Comments

Condition :   Smoking Cessation Interventions :   Behavioral: WEB;   Behavioral: Social Network;   Behavioral: Nicotine Replacement Therapy (NRT) Sponsors :   American Legacy Foundation;   National Cancer Institute (NCI) Recruiting – verified February 2012

Read More...

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

By on Monday, March 5th, 2012 | No Comments

Condition :   Diarrhea Interventions :   Drug: Elsiglutide;   Drug: Placebo Sponsor :   Helsinn Healthcare SA Not yet recruiting – verified February 2012

Read More...

Sevelamer for Reducing Endotoxemia and Immune Activation

By on Monday, March 5th, 2012 | No Comments

Condition :   HIV-1 Infection Intervention :   Drug: Sevelamer carbonate Sponsors :   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting – verified February 2012

Read More...

Irradiation of Large Lung Tumors or Two Lung Metastases Simultaneously

By on Monday, March 5th, 2012 | No Comments

Conditions :   Lung Cancer;   Metastatic Lung Cancer Interventions :   Radiation: Stereotactic Body Radiotherapy (SBRT);   Radiation: Stereotactic Body Radiotherapy (SBRT) Sponsor :   The Netherlands Cancer Institute Recruiting – verified February 2012

Read More...

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors

By on Monday, March 5th, 2012 | No Comments

Condition :   Solid Tumors Intervention :   Drug: ME-344 Sponsors :   Marshall Edwards, Inc;   Sarah Cannon Research Institute Not yet recruiting – verified February 2012

Read More...

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

By on Monday, March 5th, 2012 | No Comments

Condition :   Prostate Cancer Intervention :   Drug: 89Zr-DFO-huJ591 Sponsors :   Memorial Sloan-Kettering Cancer Center;   Weill Medical College of Cornell University;   Broad Institute of MIT and Dana-Farber Cancer Institute of Harvard Recruiting – verified February 2012

Read More...

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

By on Monday, March 5th, 2012 | No Comments

Condition :   Cystic Fibrosis Intervention :   Sponsors :   Foundation for the National Institutes of Health;   University of Southern California;   University of Minnesota – Clinical and Translational Science Institute;   M.D. Anderson Cancer Center;   Dana-Farber Cancer Institute;   Brigham and Women’s Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Amgen;   AstraZeneca;   Eli Lilly and Company;   Johnson & Johnson;   Merck;   Pfizer;   Critical Path Institute;   Predictive Safety Testing Consortium Recruiting – verified February 2012

Read More...

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

By on Monday, March 5th, 2012 | No Comments

Condition :   Ovarian Cancer Intervention :   Sponsor :   University of Washington Recruiting – verified February 2012

Read More...

Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment

By on Monday, March 5th, 2012 | No Comments

Conditions :   Breast Cancer;   Pain;   Post Operative Pain;   Lymphedema;   Neuropathy Intervention :   Sponsors :   Rigshospitalet, Denmark;   Danish Cancer Society Enrolling by invitation – verified February 2012

Read More...

X-rays reveal how soil bacteria carry out surprising chemistry

By on Monday, March 5th, 2012 | No Comments

Researchers have discovered how soil bacteria carry out surprising chemistry, defying a longstanding set of chemical rules and thus paving the way for new synthesis of polyether drugs.

Read More...
« Older Entries